1 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow QL2401 placebo 100 mg: new trials by email Literature Review of QL2401 placebo 100 mg trials Research Report on QL2401 placebo 100 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Evaluate the Efficacy and Safety of QL2401 in Patients With Metabolic Dysfunction-associated Steatohepatitis and Liver Fibrosis QL2401 25 mg, QL2401 50 mg, QL2401 100 mg - Metabolic Dysfunction-associated Steatohepatitis (MASH) | Phase 2 | Not yet recruiting | Qilu Pharmaceutical Co., Ltd. | 132 | 2026-12-01 | 2026-10-22 |